Cour Pharmaceuticals Development Company Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Cour Pharmaceuticals Development Company's estimated annual revenue is currently $12.7M per year.(i)
  • Cour Pharmaceuticals Development Company's estimated revenue per employee is $201,000

Employee Data

  • Cour Pharmaceuticals Development Company has 63 Employees.(i)
  • Cour Pharmaceuticals Development Company grew their employee count by 11% last year.

Cour Pharmaceuticals Development Company's People

NameTitleEmail/Phone
1
Founder, President and CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
CFOReveal Email/Phone
4
VP Manufacturing and Supply ChainReveal Email/Phone
5
VP Product Development and AnalyticsReveal Email/Phone
6
VP, Clinical Development OperationsReveal Email/Phone
7
VP FinanceReveal Email/Phone
8
VP Immunology & InnovationReveal Email/Phone
9
VP Technical DevelopmentReveal Email/Phone
10
VP Manufacturing and Supply ChainReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.1M6530%N/AN/A
#2
$75.6M3767%N/AN/A
#3
$23.9M11913%$35MN/A
#4
$12.7M63-3%N/AN/A
#5
$5.4M27-25%N/AN/A
#6
$6M30-35%N/AN/A
#7
$6.6M33-8%N/AN/A
#8
$13.5M67-3%N/AN/A
#9
$186.3M92719%N/AN/A
#10
$4.4M22-4%N/AN/A
Add Company

What Is Cour Pharmaceuticals Development Company?

We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures to a variety of diseases. By attacking the disease directly with our novel nanoparticle-based technologies and working strategically with our medical and scientific partners we seek to provide treatments and cures previously unavailable to doctors and their patients.

keywords:N/A

N/A

Total Funding

63

Number of Employees

$12.7M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.7M63-6%N/A
#2
$15.8M655%N/A
#3
N/A6555%N/A
#4
$5.9M6643%N/A
#5
$16M6643%N/A